Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 31, 2022 - Issue 9
Submit an article Journal homepage
403
Views
5
CrossRef citations to date
0
Altmetric
Review

Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials

Bilal Asifa Digestive Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, USAView further author information
&
Christopher Kohb Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4755-5607View further author information
ORCID Icon
Pages 905-920 | Received 14 May 2021, Accepted 03 Sep 2021, Published online: 01 Oct 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vicente Soriano, Victor Moreno-Torres, Ana Treviño, Octavio Corral & Carmen de Mendoza. (2023) Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy. Drug Design, Development and Therapy 17, pages 155-166.
Read now
Hanna Blaney, Mian Khalid, Theo Heller & Christopher Koh. (2023) Epidemiology, presentation, and therapeutic approaches for hepatitis D infections. Expert Review of Anti-infective Therapy 21:2, pages 127-142.
Read now

Articles from other publishers (3)

Nehna Abdul Majeed, Asif A. Hitawala, Theo Heller & Christopher Koh. (2023) Diagnosis of HDV : From virology to non‐invasive markers of fibrosis . Liver International.
Crossref
Vicente Soriano, Carmen de Mendoza, Ana Treviño, José Manuel Ramos‐Rincón, Víctor Moreno‐Torres, Octavio Corral & Pablo Barreiro. (2022) Treatment of hepatitis delta and HIV infection . Liver International.
Crossref
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo & Antonio Craxì. (2022) Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses 14:5, pages 986.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.